ATSP7041 is a hydrocarbon-stapled α-helical peptide engineered to inhibit specific protein-protein interactions. The stapling constraint stabilizes helix content and enhances proteolytic resistance. Researchers study its binding thermodynamics, cell permeability, and structural features by biophysical methods. Applications include PPI-modulation research, stapled-peptide technology development, and conformational-constraint studies.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.